Evidence map›Paper›PMID 36153517›Full record

ArticleBMC cancer2022

Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.

María Paula Dizanzo, Marina Bugnon Valdano, Om Basukala, Lawrence Banks, Daniela Gardiol

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

María Paula DizanzoInstituto de Biología Molecular Y Celular de Rosario-CONICET, Facultad de Ciencias Bioquímicas Y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 590. 2000, Rosario, Argentina.
Marina Bugnon ValdanoInstituto de Biología Molecular Y Celular de Rosario-CONICET, Facultad de Ciencias Bioquímicas Y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 590. 2000, Rosario, Argentina.
Om BasukalaTumour Virology Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Lawrence BanksTumour Virology Laboratory, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Daniela GardiolInstituto de Biología Molecular Y Celular de Rosario-CONICET, Facultad de Ciencias Bioquímicas Y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 590. 2000, Rosario, Argentina. gardiol@ibr-conicet.gov.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARInternational Centre for Genetic Engineering and Biotechnology · IT

Funding

Associazione Italiana per la ricerca sul Cancro Grant IG 2019 23572
6 · The paper itself

Abstract

backgroundOncogenic Human Papillomaviruses (HPVs) base their transforming potential on the action of both E6 and E7 viral oncoproteins, which perform cooperative or antagonistic actions and thus interfere with a variety of relevant cellular targets. Among them, the expression of some PDZ-containing polarity proteins, as DLG1 and hScrib, is altered during the HPV life cycle and the consequent malignant transformation. Together with the well-established interference of E6 with PDZ proteins, we have recently shown that E7 viral oncoprotein is also responsible for the changes in abundance and localization of DLG1 observed in HPV-associated lesions. Given that the mechanisms involved remained only partially understood, we here thoroughly analyse the contribution of a crucial E7 post-translational modification: its CKII-dependent phosphorylation. Moreover, we extended our studies to hScrib, in order to investigate possible conserved regulatory events among diverse PDZ targets of HPV.

methodsWe have acutely analysed the expression of DLG1 and hScrib in restrictive conditions for E7 phosphorylation by CKII in epithelial culture cells by western blot and confocal fluorescence microscopy. We made use of genome-edited HPV-positive cells, specific inhibitors of CKII activity and transient expression of the viral oncoproteins, including a mutant version of E7.

resultsWe here demonstrate that the functional phosphorylation of E7 oncoprotein by the CKII cellular kinase, a key regulatory event for its activities, is also crucial to counteract the E6-mediated degradation of the PDZ-polarity protein DLG1 and to promote its subcellular redistribution. Moreover, we show that the CKII-dependent phosphorylation of E7 is able to control the expression of another PDZ target of HPV: hScrib. Remarkably, we found this is a shared feature among different oncogenic HPV types, suggesting a common path towards viral pathogenesis.

conclusionsThe present study sheds light into the mechanisms behind the misexpression of PDZ-polarity proteins during HPV infections. Our findings stress the relevance of the CKII-mediated regulation of E7 activities, providing novel insights into the joint action of HPV oncoproteins and further indicating a conserved and most likely crucial mechanism during the viral life cycle and the associated transformation.

Indexed as

Oncogene Proteins, ViralPapillomavirus InfectionsCell Transformation, NeoplasticHumansPapillomaviridaePapillomavirus E7 ProteinsProtein Processing, Post-TranslationalOncogene Proteins, ViralPapillomavirus E7 ProteinsCKIIDLG1 hScribHPV E7PDZ

Identifiers

PMID36153517
PMCPMC9509620
OpenAlexW4297201143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.